Singapore National Eye Centre, Singapore; Singapore Eye Research Institute, Singapore; Ophthalmology and Visual Sciences Academic Clinical Programme, SingHealth Duke-NUS Academic Medical Centre, Duke-NUS Graduate Medical School, Singapore.
Department of Ophthalmology, Sorocaba Eye Hospital, Sorocaba Eye Bank, Sorocaba, São Paulo, Brazil; Department of Ophthalmology, Federal University of São Paulo, São Paulo, Brazil.
Exp Eye Res. 2021 Apr;205:108474. doi: 10.1016/j.exer.2021.108474. Epub 2021 Jan 29.
Presbyopia is a growing problem in view of an aging global population and increasingly patients desire spectacle-free solutions to address this condition. Surgically implanted corneal inlays have been the topic of renewed research efforts in the past several years as a treatment option for presbyopia, with several approaches being used to modify the refractive properties of the cornea and enhance near vision. In this review we discuss historical approaches to corneal inlay surgery, critically appraise the current generation of presbyopia-correcting corneal inlays and their associated complications and consider the future prospects for emerging corneal inlay technologies that aim address the shortcomings of currently available inlays.
随着全球人口老龄化，老花眼的问题日益严重，越来越多的患者希望有一种无需佩戴眼镜的解决方案来解决这个问题。因此，近年来，外科植入式角膜内镜片作为老花眼的治疗选择再次成为研究热点，人们尝试了多种方法来改变角膜的屈光特性，从而提高近视力。在本文中，我们讨论了角膜内镜片手术的历史方法，批判性地评估了目前一代用于矫正老花眼的角膜内镜片及其相关并发症，并考虑了新兴角膜内镜片技术的未来前景，这些技术旨在解决目前可用内镜片的缺点。
